Methylene Blue Dosage Guide: Protocols, Calculator & Safety
Everything you need to know about Methylene Blue dosing — protocols, safety, and where to buy.
Dose Range
0.5 mg - 4 mg/kg daily (oral)
Dosage Calculator
Calculate exact dosing for Methylene Blue.
Dosing Protocols
Entry-level nootropic protocol (first 4-8 weeks)
Goal: Establish tolerance, confirm sourcing, detect G6PD or serotonergic interactions before escalating.
Prerequisites (do these BEFORE first dose)
- G6PD enzyme test — LabCorp test code 001917 (~$60 out-of-pocket) or included in most comprehensive metabolic panels. If G6PD deficient, stop. MB is contraindicated.
- Serotonergic washout — confirm no SSRI/SNRI/tramadol/MDMA/5-HTP/St. John's Wort for at least 2 weeks (5 half-lives for most SSRIs).
- USP pharmaceutical-grade MB only — vendor must provide third-party COA documenting >99% purity and heavy-metal testing. See COA Verification Guide.
- Liquid MB: typical concentration 1% w/v = 10 mg/mL or 50 mg/mL for more concentrated preparations. Use oral dosing syringe with 0.1 mL graduations minimum. Dilute drops in 50-100 mL water or juice to prevent mucosal staining.
Week 1 — microdose tolerance test
- Day 1: 1 mg (0.1 mL of 10 mg/mL preparation) in morning with food. Observe for headache, nausea, serotonergic symptoms (flushing, anxiety, tremor). Stop if any.
- Day 2-3: repeat 1 mg if tolerated.
- Day 4-7: 2 mg in morning.
Week 2-4 — titration to effective dose
- Increase by 1-2 mg every 3-4 days as tolerated.
- Target: 5-10 mg in morning, daily or 5 days/week. Most users report peak cognitive effect at this dose range; going above 15 mg often reduces benefit (inverted-U).
- Pair with a modest breakfast (fat + protein) to reduce GI effects.
Week 5-8 — stabilization
- Maintain 5-10 mg/day with a 2-day per week holiday.
- Track with a simple cognitive battery (Dual N-Back, Quantified Mind, or Cambridge Brain Sciences) pre-dose and 2 hours post-dose, twice weekly.
- Expect blue urine (normal), mild metallic taste, subtle improvement in verbal fluency and sustained attention.
Red flags — stop and consult a clinician
- Any serotonergic symptoms (agitation, tremor, fever, muscle rigidity, diarrhea)
- Dark urine (beyond the expected blue-green) or jaundice (hemolysis signal)
- Shortness of breath, chest pain, or cyanosis (methemoglobinemia)
- Persistent headache not responsive to dose reduction
Do NOT start at the "anti-aging 4 mg/kg" dose you will see cited online. That is a rodent dose; the equivalent human surface-area-corrected dose is closer to 0.5-0.6 mg/kg (~35-45 mg for a 75 kg adult), which is the upper end of the cognitive window, not the beginner dose.
Intermediate mitochondrial protocol (months 2-6)
Assumes successful completion of beginner protocol, no adverse events, documented USP sourcing, negative G6PD testing.
Daily dosing window
- 10-20 mg/day in morning (0.1-0.25 mg/kg for a 75 kg adult).
- Pair with breakfast containing fat (improves absorption).
- Morning is non-negotiable for daily protocols — even low-dose MB can disrupt sleep onset in sensitive users.
Red-light stacking (optional)
- After MB absorption (~45-60 min post-dose), 10-20 minutes of red-light (660 nm) or near-infrared (810 nm) exposure at 20-100 mW/cm² from a clinical-grade panel.
- Rationale: MB absorbs these wavelengths and generates targeted singlet oxygen; anecdotal reports suggest amplified cognitive effect. Human RCT evidence is limited.
Cycling
- Common patterns: 5 days on, 2 days off (weekday dosing only), or 4 weeks on, 1 week off.
- Rationale: limit pro-oxidant accumulation at the high end of the cognitive window; preserve sensitivity.
Cognitive tracking
- Run pre-/post-cycle Cambridge Brain Sciences or Dual N-Back battery monthly.
- Track subjective metrics (sleep quality, exercise recovery, mood) in parallel.
Lab monitoring
- CBC with methemoglobin at 3 and 6 months. Methemoglobin should remain <1%.
- Comprehensive metabolic panel (renal and liver function) at 6 months.
- Iron studies if you notice fatigue (MB can interact with iron homeostasis via its redox chemistry at higher doses).
When to escalate or not
- Above 20-30 mg/day, the evidence base shifts from nootropic to therapeutic (Alzheimer's, vasoplegia). Do not escalate for "more cognitive effect" — the inverted-U means higher doses reduce, not improve, cognitive benefit.
- Acute "therapeutic" doses (50-100 mg) are only indicated under medical supervision for specific conditions.
Advanced / therapeutic protocol (clinical supervision required)
This tier includes doses and combinations that should not be self-administered without a knowledgeable clinician and is included here for informational parity with the published literature.
Alzheimer's / tau-directed (TauRx-style regimen)
- 8-16 mg hydromethylthionine mesylate (TRx0237) twice daily = 16-32 mg/day total.
- Monitoring: MMSE/ADAS-Cog every 3 months; MRI hippocampal volume annually; CBC + methemoglobin quarterly.
- Not a DIY protocol. TRx0237 is an investigational agent; extrapolating from methylene blue USP is pharmacokinetically similar but not identical. Enroll in a TauRx trial or work with a specialist.
Chronic fatigue / post-viral mitochondrial dysfunction (case-report basis)
- Short trials of 15-30 mg MB/day for 4-6 weeks have been reported in small long-COVID case series. No RCT evidence.
- If pursuing, do so with a clinician who can monitor CBC, methemoglobin, and autonomic symptoms.
Intravenous MB for methemoglobinemia (FDA-indicated, clinician only)
- 1-2 mg/kg IV over 5 minutes, repeatable to max 7 mg/kg cumulative dose.
- This is the life-saving emergency dose — not a biohacking use case. Included only for context.
Septic shock / vasoplegia (clinician only, off-label)
- 1-2 mg/kg IV load, then 0.25-2 mg/kg/hr infusion for up to 6 hours.
- Used in ICU for catecholamine-resistant vasoplegia after cardiac bypass.
Photodynamic therapy (clinical dermatology / oncology)
- 1% topical MB + 635-nm red light for actinic keratosis, basal cell carcinoma (off-label). Separate evidence base from oral cognitive use.
General rules at this tier
- Never combine with any serotonergic agent without a full 2-week washout.
- Always have CBC with methemoglobin available.
- Monitor oxygen saturation — MB artifactually depresses pulse oximetry SpO₂ readings by ~5% for 30-60 minutes after IV administration.
- Pregnancy is an absolute contraindication.
Commonly Stacked With
Standard pairings
- Near-infrared / red light (660 nm / 810 nm) photobiomodulation — MB absorbs red/NIR wavelengths and generates targeted oxidative signaling that compounds the mitochondrial effect. Anecdotal user reports are strong; controlled human data for cognitive endpoints is thin.
- Coenzyme Q10 (100-200 mg/day) or ubiquinol (100-200 mg/day) — direct downstream support of the electron transport chain. Logical pairing for mitochondrial dysfunction; well-tolerated.
- PQQ (10-20 mg/day) — mitochondrial biogenesis inducer; complements MB's activity rather than duplicates it.
- Creatine (3-5 g/day) — independent mitochondrial support; the creatine-phosphocreatine system buffers the ATP that MB's electron shunting ultimately produces.
- Nicotinamide riboside / NMN — NAD+ precursors. MB directly accepts electrons from NADH, so sufficient NAD+ pools are required for MB's mechanism to operate. See NAD+ compound page for precursor selection.
Biohacking-specific stacks
- Cognitive / focus stack: 5-15 mg MB (sublingual) + caffeine 100-200 mg + L-theanine 200 mg + optional 200 mg Alpha-GPC. Take in morning.
- Longevity / mitochondrial stack: 5 mg MB + 300 mg CoQ10 + 10 mg PQQ + 500 mg resveratrol with fat.
- Post-exercise recovery: 1-4 mg MB with creatine 5 g. Avoid if heart rate reserve is compromised.
Pairings to avoid
- Any serotonergic drug or supplement (SSRIs, SNRIs, triptans, tramadol, MDMA, 5-HTP, L-tryptophan, St. John's Wort, dextromethorphan) — serotonin syndrome risk.
- Nitrates / nitrites (amyl nitrite "poppers", isosorbide, nitroglycerin) — conflict with MB's effect on NO signaling; vasoplegic or hypertensive risk.
- Drugs that cause methemoglobinemia (dapsone, benzocaine, prilocaine, high-dose nitric oxide donors) — additive methemoglobinemia risk.
- Other MAO inhibitors (selegiline, rasagiline, moclobemide, phenelzine) — additive MAOI effect.
- Alcohol — the night-of-dosing combination worsens headaches and blunts the mitochondrial benefit.
Timing
MB has a plasma half-life of ~5-6 hours (oral) and a tissue half-life of ~12-24 hours. Morning dosing prevents sleep-onset issues. Daily dosing is tolerated in the low-dose window; cycling 5-days-on, 2-days-off or 2-weeks-on, 1-week-off is common among long-term users to limit pro-oxidant accumulation.
Related Compounds — Deeper Research Paths — Methylene blue's mitochondrial-electron-bypass action pairs naturally with other mito/NAD compounds: NAD+, NMN, CoQ10 (shares electron transport; methylene blue bypasses Complex I blockage), SS-31, MOTS-c, Urolithin A (mitophagy). Cognitive stacks leverage methylene blue's cytochrome-c-oxidase effect plus cholinergic/dopaminergic tone: Alpha-GPC, CDP-Choline, Semax, Dihexa, Bromantane. Longevity context: Rapamycin, Fisetin, Dasatinib + quercetin.
Side Effects & Safety
Contraindications
**Absolute contraindications (do not use at therapeutic doses)** - **G6PD deficiency** — causes acute hemolytic anemia. Test before use. - **Pregnancy** — crosses placenta; causes fetal hemolysis and methemoglobinemia. - **Current SSRI/SNRI/serotonergic drug therapy** — serotonin syndrome risk. Full washout required. - **Infants <4 months** — limited hepatic metabolism; risk of methemoglobinemia. - **Severe renal impairment (eGFR <30)** — accumulation risk; avoid or dose-reduce dramatically. **Relative contraindications (clinician-guided only)** - Hepatic impairment (Child-Pugh B or higher) - Known methemoglobinemia-inducing drug therapy (dapsone, benzocaine, high-dose nitrates) - Hemolytic anemia of any etiology - History of serotonin syndrome - Phenylketonuria (some formulations contain phenylalanine) - Active photosensitivity disorders (porphyria, lupus with photosensitivity) **Surgery and procedural considerations** - **Pulse oximetry interference:** MB falsely depresses SpO₂ readings by ~5% for 30-60 min after administration. Inform anesthesia team if you have dosed recently. - **Co-oximetry is unaffected** — use for true oxygenation assessment. - **Serotonergic anesthetics:** Many perioperative agents (fentanyl, tramadol, dexmedetomidine at very high doses) have serotonergic activity. Disclose MB use to anesthesia at pre-op. **What to disclose to any clinician** - Dose, frequency, brand/vendor - Duration of use - Most recent dose (especially within 72 hours) - All concurrent supplements (many users forget that 5-HTP, St. John's Wort, tryptophan count as serotonergic)
Additional Notes
Oral dosing reference table
| Dose | Indication | Evidence |
|---|---|---|
| 0.5-2 mg/day | Tolerance testing, microdose | Self-titration, no RCT |
| 5-15 mg/day | Nootropic / mitochondrial | Rodriguez 2016 fMRI (280 mg was used but scales down) |
| 16-32 mg/day | Alzheimer's (TRx0237) | Wilcock 2023, LUCIDITY Phase 3 |
| 50-100 mg single dose | Acute cognition research | Rodriguez 2016 (280 mg single dose) |
| 1-2 mg/kg IV | Methemoglobinemia | FDA-indicated |
Practical measurement
1% USP MB = 10 mg/mL. A 0.1 mL drop = 1 mg. Use a graduated oral dosing syringe (0.1 mL increments), never eyeball it.
Timing
- Morning always. Half-life 5-6 hours plasma, 12-24 hours tissue.
- With food (fat + protein breakfast) reduces GI effects.
- Pre-workout dosing (~30-60 min before exercise) is common but unstudied.
Sublingual vs oral
- Sublingual bypasses first-pass metabolism and produces faster onset (15-30 min) with roughly 30-50% higher bioavailability than swallowed MB. Trade-off: extends mucosal staining; always dilute.
IV vs oral
- IV bioavailability 100%; oral ~72%. IV use is limited to clinician-administered methemoglobinemia treatment and vasoplegia. Not a biohacking modality.
Storage
- Amber glass bottle, room temperature (15-25°C), out of direct light. Stable for 2+ years if sealed.
- Avoid plastic — MB stains and can leach plasticizers over time.
- Refrigeration not required.
Where to Buy Methylene Blue
Compare 2 listings across 2 vendors — from $19.99
Frequently Asked Questions
What is the recommended Methylene Blue dosage?
The typical dose range for Methylene Blue is 0.5 mg - 4 mg/kg daily (oral). Always start with the lowest effective dose.
How often should I take Methylene Blue?
Administration frequency depends on the specific protocol. Consult current research literature.
Does Methylene Blue need to be cycled?
Cycling requirements depend on the protocol. Follow established research guidelines.
What are Methylene Blue side effects?
**Expected / benign** - **Blue-green urine and stool** — universal, not a problem, clears within 24-48 hours of last dose. - **Blue discoloration of sclera and skin** at sustained higher doses; reversible. - **Metallic taste** and mild mucosal tingling at oral doses >30 mg. - Mild stimulation / wakefulness in some users; others report sedation. Take in morning until you know your response. **Dose-dependent / avoidable** - Nausea, GI upset — almost always from taking on empty stomach or from non-USP material. Take with food. - Headache at doses above ~40 mg in the cognitive window; frequently resolves by cutting dose in half. - Paradoxical cognitive dulling above ~5 mg/kg — the inverted-U. If you feel "foggy" on MB, you are dosed too high. - Methemoglobinemia itself — rare but possible with very high oral doses (>7 mg/kg) or repeated dosing in G6PD-normal individuals. **Serious — contraindications** - **G6PD deficiency (absolute contraindication at therapeutic doses):** MB causes acute hemolytic anemia in G6PD-deficient patients because the reduction pathway depends on NADPH. Get a G6PD test before ever using more than a microgram-range dose, particularly if you have African, Mediterranean, or Middle Eastern ancestry (5-30% prevalence). - **Pregnancy:** MB crosses the placenta and causes fetal hemolytic anemia, jaundice, and methemoglobinemia (especially intra-amniotic exposure). Avoid. - **Renal impairment:** Reduced clearance; dose-reduce and ideally avoid. - **Photosensitivity:** Especially with sun exposure while dosing. **Drug interactions — serotonin syndrome risk (life-threatening)** Because MB is a **potent reversible MAO-A inhibitor at standard oral doses**, combining it with any serotonergic drug can trigger serotonin syndrome (hyperthermia, rigidity, autonomic instability, death). Absolute wash-out of **at least 2 weeks, ideally 5 half-lives** of the serotonergic agent before MB: - SSRIs (sertraline, fluoxetine, paroxetine, citalopram, escitalopram) - SNRIs (venlafaxine, duloxetine, desvenlafaxine) - Tramadol, meperidine, tapentadol - MDMA, MDA, mephedrone - Dextromethorphan - Triptans (sumatriptan, etc.) - Linezolid (also MAOI) - St. John's Wort - 5-HTP, L-tryptophan supplements - TCAs (caution with partial-agonist mechanisms) - Lithium (serotonin-potentiating) Also avoid: MAO-B inhibitors (selegiline, rasagiline) — additive CNS effects; CYP1A2 substrates (narrow therapeutic index) — MB is a weak inhibitor. **Quality/contamination hazards** - Industrial-grade methylene blue (textile, aquarium, laboratory ACS-grade) routinely exceeds EU/WHO limits for arsenic, cadmium, mercury, and lead. Do not ingest. Use USP pharmaceutical-grade with third-party COA only.
Where can I buy Methylene Blue?
Compare 2 listings from 2 vendors on our price comparison page — starting from $19.99.
Free 2026 Peptide Cheat Sheet — 50 pages, PDF
Dosing, reconstitution, stacks, half-lives, and vendor trust tiers. The reference we wish we had on day one.